Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
Author Archives for Adeline Chauvigné
Valneva Announces the Pricing of its Initial Public Offering on Nasdaq
11 May 2025Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
Clinical Study demonstrates promising results for Investigative ALS Treatment; InFlectis BioScience is planning phase 2 trial of Next-Generation Therapy
A new study shows indications that Amyotrophic Lateral Sclerosis (ALS) may be treated with small molecules targeting the Integrated Stress... View Article
Clinical Study demonstrates promising results for Investigative ALS Treatment; InFlectis BioScience is planning phase 2 trial of Next-Generation Therapy
11 May 2025A new study shows indications that Amyotrophic Lateral Sclerosis (ALS) may be treated with small molecules targeting the Integrated Stress... View Article
CLEAN BIOLOGICS SAS ACQUIRES BIODEXTRIS INC.
The transaction enables the ArchiMed-backed Clean Biologics group to establish North American presence and expand their activities with Biodextris’ complementary... View Article
CLEAN BIOLOGICS SAS ACQUIRES BIODEXTRIS INC.
11 May 2025The transaction enables the ArchiMed-backed Clean Biologics group to establish North American presence and expand their activities with Biodextris’ complementary... View Article
XENOTHERA And Its Partner Excelya Announce the Recruitment of the First Patient in The EUROXAV Clinical Trial of its COVID Treatment XAV-19
#COVID19 #ClinicalTrial #Treatment #PolyclonalAntibodies The biotech company XENOTHERA has begun the European clinical trial of its anti-COVID treatment, XAV-19. The Nantes laboratory... View Article
XENOTHERA And Its Partner Excelya Announce the Recruitment of the First Patient in The EUROXAV Clinical Trial of its COVID Treatment XAV-19
11 May 2025#COVID19 #ClinicalTrial #Treatment #PolyclonalAntibodies The biotech company XENOTHERA has begun the European clinical trial of its anti-COVID treatment, XAV-19. The Nantes laboratory... View Article
WAVEIMPLANT winner of the Tech Tour France 2021
WAVEIMPLANT, a young innovative company developing ImplantUS, a medical device for measuring the stability of dental implants and securing associated... View Article
WAVEIMPLANT winner of the Tech Tour France 2021
11 May 2025WAVEIMPLANT, a young innovative company developing ImplantUS, a medical device for measuring the stability of dental implants and securing associated... View Article
New member | MedHey
MedHey is a startup operating in the digital health field which aims at breaking down the barriers between healthcare professionals. This startup... View Article
New member | MedHey
11 May 2025MedHey is a startup operating in the digital health field which aims at breaking down the barriers between healthcare professionals. This startup... View Article
Valneva announces launch of proposed global offering, start of the roadshow and Nasdaq listing
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
Valneva announces launch of proposed global offering, start of the roadshow and Nasdaq listing
11 May 2025Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
XENOTHERA’s anti-COVID XAV-19 treatment: the end of the POLYCOR inclusions clinical trial promoted by the Nantes University Hospital
The biotech XENOTHERA and the Nantes University Hospital announce the end of the inclusions of the second phase of the... View Article
XENOTHERA’s anti-COVID XAV-19 treatment: the end of the POLYCOR inclusions clinical trial promoted by the Nantes University Hospital
11 May 2025The biotech XENOTHERA and the Nantes University Hospital announce the end of the inclusions of the second phase of the... View Article
Testing a new robot at Nantes University Hospital
A trial of the HUSKY-UV, a UV disinfection robot, took place in the Thoracic Endoscopy Unit at Nord Laennec Hospital... View Article
Testing a new robot at Nantes University Hospital
11 May 2025A trial of the HUSKY-UV, a UV disinfection robot, took place in the Thoracic Endoscopy Unit at Nord Laennec Hospital... View Article
Research | CAR-T cells are revolutionising cancer treatment
LYSA (the lymphoma research group) has just launched the 1st French academic study of CAR-T cells. Named ALYCANTE, this study... View Article
Research | CAR-T cells are revolutionising cancer treatment
11 May 2025LYSA (the lymphoma research group) has just launched the 1st French academic study of CAR-T cells. Named ALYCANTE, this study... View Article